R

Rigel Pharmaceuticals Inc.

276 employees

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients hematologic disorders, cancer and rare immune diseases.

Investor insights

Funding rounds participated in

$17M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

1996

Funding rounds raised

Total raised

$17M

from 1 investors over 1 rounds

R

Rigel Pharmaceuticals Inc. raised $17M on March 1, 2021

Investors: U.S. Department of Defense